Clinical Trial Detail

NCT ID NCT01723020
Title A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Amgen
Indications

Advanced Solid Tumor

multiple myeloma

Therapies

AMG 232

Age Groups: adult

No variant requirements are available.